| 5T3S: reference: HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies., Steichen JM, Kulp DW, Tokatlian T, Escolano A, Dosenovic P, Stanfield RL, McCoy LE, Ozorowski G, Hu X, Kalyuzhniy O, Briney B, Schiffner T, Garces F, Freund NT, Gitlin AD, Menis S, Georgeson E, Kubitz M, Adachi Y, Jones M, Mutafyan AA, Yun DS, Mayer CT, Ward AB, Burton DR, Wilson IA, Irvine DJ, Nussenzweig MC, Schief WR, Immunity. 2016 Sep 20;45(3):483-96. doi: 10.1016/j.immuni.2016.08.016. Epub 2016 , Sep 8. PMID: 27617678 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).